🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.90
-3.10 (-10.00%)
Nov 20, 2026, 1:30 PM CST

Taiwan Biomaterial Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
153.37220.496.5772.84127.3141.67
Revenue Growth
-24.55%128.22%32.59%-42.79%205.48%130.56%
Cost of Revenue
76.185.6139.2725.7236.949.52
Gross Profit
77.27134.857.3147.1290.3732.15
Selling, General & Admin
58.8950.4137.4638.5732.7923.46
Research & Development
26.1823.5531.0822.7832.1265.41
Operating Expenses
85.0773.9668.5461.3564.9188.87
Operating Income
-7.860.83-11.24-14.2325.46-56.72
Interest Expense
-0.71-0.74-0.8-0.87-0.97-1.03
Interest & Investment Income
3.985.383.844.72.250.49
Currency Exchange Gain (Loss)
-6.89-6.893.670.276.67-0.63
Other Non Operating Income (Expenses)
19.440.350.781.10.3410.48
EBT Excluding Unusual Items
8.0258.93-3.75-9.0333.76-47.4
Gain (Loss) on Sale of Assets
------0.04
Pretax Income
8.0258.93-2.49-9.0333.76-47.44
Income Tax Expense
---0.761.1--
Net Income
8.0258.93-1.73-10.1333.76-47.44
Net Income to Common
8.0258.93-1.73-10.1333.76-47.44
Net Income Growth
-85.91%-----
Shares Outstanding (Basic)
424242424133
Shares Outstanding (Diluted)
424242424133
Shares Change
0.81%--2.73%23.90%-
EPS (Basic)
0.191.40-0.04-0.240.83-1.44
EPS (Diluted)
0.191.40-0.04-0.240.83-1.44
EPS Growth
-86.21%-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-110.4447.3314.74-12.74-6.36-54.3
Free Cash Flow Per Share
-2.611.130.35-0.30-0.16-1.65
Dividend Per Share
-1.000--0.200-
Dividend Growth
------
Gross Margin
50.38%61.16%59.34%64.69%70.99%77.15%
Operating Margin
-5.08%27.60%-11.63%-19.53%20.00%-136.10%
Profit Margin
5.23%26.74%-1.79%-13.91%26.52%-113.84%
Free Cash Flow Margin
-72.01%21.47%15.26%-17.49%-5.00%-130.31%
EBITDA
3.4171.970.99-2.2836.02-51.8
EBITDA Margin
2.22%32.65%1.03%-3.14%28.29%-124.29%
D&A For EBITDA
11.2111.1412.2311.9410.554.92
EBIT
-7.860.83-11.24-14.2325.46-56.72
EBIT Margin
-5.08%27.60%-11.63%-19.53%20.00%-136.10%